WebBenefits from statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) are supported by high-quality evidence from randomised controlled trials (RCT). However, when and how to prescribe statins to individuals without ASCVD is a matter of debate. Web13 de abr. de 2024 · The risk for recurrent atherosclerotic cardiovascular disease (ASCVD) events is high following hospital discharge for a myocardial infarction (MI) [1, 2].The …
Natural Language Processing to Identify Reasons for Sex Disparity …
Web28 de mar. de 2024 · Disparities in statin use persist in high-risk Americans. Publish date: March 28, 2024. By ... The study divided ASCVD risk strata into three groups – 5% to less than 7.5%, 7.5% to less than 20%, and more than 20% – based on the 2024 ACC/AHA guideline and used pooled cohort equation to calculate 10-year ASCVD risk, ... Web21 de out. de 2024 · Statin treatment, especially in higher doses in the elderly, increases the risk of new-onset diabetes (number needed to harm 255 per 4 years of treatment). Still, the above described benefits of statin treatment clearly outweigh the small increase in … thepowerof10 uk
Guideline Quiz: ACC Update on Non-Statin Therapy for ASCVD
Web8 de abr. de 2024 · Statin medications can treat lipids by slowing down plaque formation and stabilizing ones that already exist. Treating conditions like diabetes helps to prevent more damage to blood vessels. Some people at high risk of ASCVD take antiplatelet medication, like an aspirin every day. Web29 de abr. de 2024 · Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol (LDL-C) levels (≥190 mg/dL), … Web16 de dez. de 2024 · Therefore, it may be reasonable to target blood pressure <130/80 mmHg among patients with diabetes and either clinically diagnosed cardiovascular disease (particularly stroke, which was significantly reduced in ACCORD BP) or 10-year ASCVD risk ≥15%, if it can be attained safely. the power of 0 rule